Company intelligence / Profile preview

InfinixBio

Columbus, Ohio, United Statesinfinixbio.com ↗

Ownership: Private
Development stage: Other

Overview

InfinixBio is an established biotech Contract Research Organization specializing in drug discovery, pharmacology, and clinical diagnostics. The company provides comprehensive R&D services from early drug development through clinical trials and regulatory approval. Their team includes 38% PhDs with over 60 issued or pending patents. They are known for innovative problem-solving and supporting clients through complex regulatory pathways[1][2][3].

Modalities: Small moleculeProteinMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Works with virtual/mid-size biotech companies, industry consulting firms, pharmaceutical companies; specific partnerships are confidential but include Bexion Pharmaceuticals and Sonnet BioTherapeutics as referenced by testimonials[2]

Beyond the preview

Go deeper on InfinixBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InfinixBio.

Explore the full profile